Comparison of hhCG With hCG+ß in the Early Prediction of Ongoing Pregnancy.

Instituto Valenciano de Infertilidad, IVI VALENCIA156 enrolled

Overview

Proof of concept study for the prediction of ongoing pregnancy in women undergoing In-Vitro Fertilization (IVF), using hyperglycosylated human chorionic gonadotropin (hhCG), early after In-Vitro Fertilization and fresh Embryo Transfer (IVF-ET).

Study Type

INTERVENTIONAL

Allocation

Purpose

DIAGNOSTIC

Masking

NONE

Enrollment

156

Conditions

Pregnancy Test

Interventions

Pregnancy testDIAGNOSTIC_TEST

Instead of one blood sample, patients will have three blood analyses to predict pregnancy earlier after the embryo transfer.

Eligibility

Sex: FEMALEMin age: 18 YearsMax age: 45 Years

Medical Language ↔ Plain English

Inclusion criteria: * Written informed consent * Patients undergoing their first or second IVF-ET cycle * Age 18-45 years * Use of Ovitrelle for final follicular maturation and luteinization * Fresh or Frozen day-5 blastocysts transrer (Autologus or Egg donation) Exclusion criteria: * Gestational surrogacy (patient's eggs used for pregnancy in a surrogate mother) * Canceled IVF cycles * GnRH agonist triggering cycles in the case of fresh ET.

Locations (1)

IVI Valencia

Valencia, Spain

Outcomes

Primary Outcomes

Number of Participants With Early Detection of Pregnancy

Detection of Pregnancy on earlier dates (before day-11 after Embrio transfer)

Time frame: One month

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.